VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Adjusted EPS | ₹21.31 | ₹19.87 | ₹30.47 | ₹50.04 | ₹-8.10 |
What is the latest Earnings Per Share (EPS) of VENUS REMEDIES ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹21.31 |
Mar2023 | ₹19.87 |
Mar2022 | ₹30.47 |
Mar2021 | ₹50.04 |
Mar2020 | ₹-8.10 |
How is Earnings Per Share (EPS) of VENUS REMEDIES Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹21.31 | 7.25 | |
Mar2023 | ₹19.87 | -34.79 | |
Mar2022 | ₹30.47 | -39.11 | |
Mar2021 | ₹50.04 | Positive | |
Mar2020 | ₹-8.10 | - |
Compare Earnings Per Share (EPS) of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹482.5 Cr | 24.5% | 21.8% | -9.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 24.5% |
21.8% |
-9.1% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses